Advocacy intelligence hub — real-time data for patient organizations
University of Alabama at Birmingham — PHASE2
University of Minnesota — EARLY_PHASE1
AeRang Kim — PHASE1, PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
National Cancer Institute (NCI) — PHASE1
National Cancer Institute (NCI) — PHASE2
Washington University School of Medicine — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Xing Zhang
Sun Yat-Sen University Cancer Center
📍 PAOLI, PA
Brigitte C. Widemann, MD, M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Robert Maki, MD, PhD, MD, PhD
Memorial Sloan Kettering Cancer Center
📍 PHILADELPHIA, PA
Joanne Lagmay, MD, MD
University of Florida
📍 GAINESVILLE, FL
AeRang Kim, MD, PhD, M.D
Children's National Research Institute
📍 BETHESDA, MD
View all Malignant peripheral nerve sheath tumor specialists →